In line with these findings, a greater number of clonal B-cells (≥15 × 109/L) and total PC counts (≥3.3 cells/μL), the presence of del(17p) (TP53), and an unmutated IGHV gene status were all associated with a shorter TFT among CLL A/0 patients (Figure S2). The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.